Paul McBarron, E.V.P, Finance & C.O.O at Cyclacel Pharmaceuticals, Inc. (CYCC), bought 1,950 shares at $2.25 ($4K) on 2008-05-22, disclosed to the SEC on 2008-05-23.
Open-market purchase of $4k CYCC by E.V.P, Finance & C.O.O. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| CYCC | BUY | 2011-09-26 | $6K | — | Filing → |